Article
Proteomic characterization of Her2/neu‐overexpressing breast cancer cells
3 Sept 2010
Abstract excerpt
The receptor tyrosine kinase HER2 is an oncogene amplified in invasive breast cancer and its overexpression in mammary epithelial cell lines is a strong determinant of a tumorigenic phenotype. Accordingly, HER2-overexpressing mammary tumors are commonly indicative of a poor prognosis in patients. Several quantitative proteomic studies have employed two-dimensional gel electrophoresis in combination with MS/MS,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
